Assenagon Asset Management S.A. Raises Holdings in Cardlytics, Inc. (NASDAQ:CDLX)

Assenagon Asset Management S.A. lifted its stake in shares of Cardlytics, Inc. (NASDAQ:CDLX - Free Report) by 540.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 97,351 shares of the company's stock after acquiring an additional 82,152 shares during the quarter. Assenagon Asset Management S.A. owned approximately 0.25% of Cardlytics worth $897,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently made changes to their positions in CDLX. FMR LLC raised its position in shares of Cardlytics by 238.4% during the second quarter. FMR LLC now owns 1,428 shares of the company's stock worth $32,000 after acquiring an additional 1,006 shares during the last quarter. Tower Research Capital LLC TRC grew its stake in Cardlytics by 220.6% during the third quarter. Tower Research Capital LLC TRC now owns 3,405 shares of the company's stock worth $32,000 after purchasing an additional 2,343 shares during the period. Point72 Middle East FZE acquired a new stake in Cardlytics during the fourth quarter worth approximately $35,000. Point72 Hong Kong Ltd acquired a new stake in Cardlytics during the second quarter worth approximately $38,000. Finally, Comerica Bank acquired a new stake in Cardlytics during the third quarter worth approximately $40,000. 68.10% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on CDLX shares. Lake Street Capital raised their target price on Cardlytics from $13.00 to $18.00 and gave the stock a "buy" rating in a research note on Friday, March 15th. Needham & Company LLC raised their target price on Cardlytics from $12.00 to $15.00 and gave the stock a "buy" rating in a research note on Friday, March 15th. Finally, Craig Hallum raised Cardlytics from a "hold" rating to a "buy" rating and raised their target price for the stock from $10.00 to $18.00 in a research note on Friday, March 15th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $13.20.

Cardlytics Stock Up 4.6 %

Cardlytics stock traded up $0.60 during mid-day trading on Friday, reaching $13.67. The stock had a trading volume of 804,983 shares, compared to its average volume of 3,579,224. The company has a debt-to-equity ratio of 1.91, a quick ratio of 1.31 and a current ratio of 1.31. Cardlytics, Inc. has a fifty-two week low of $4.70 and a fifty-two week high of $20.52. The stock's 50-day simple moving average is $9.63 and its 200-day simple moving average is $9.74. The firm has a market capitalization of $602.98 million, a PE ratio of -3.95 and a beta of 1.44.

Cardlytics (NASDAQ:CDLX - Get Free Report) last announced its quarterly earnings data on Thursday, March 14th. The company reported ($0.14) EPS for the quarter. Cardlytics had a negative net margin of 43.56% and a negative return on equity of 25.38%. The firm had revenue of $89.17 million during the quarter.

Insider Buying and Selling at Cardlytics

In related news, insider Nicholas Hollmeyer Lynton sold 12,460 shares of Cardlytics stock in a transaction that occurred on Tuesday, April 2nd. The stock was sold at an average price of $13.69, for a total transaction of $170,577.40. Following the transaction, the insider now owns 71,355 shares of the company's stock, valued at $976,849.95. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, insider Nicholas Hollmeyer Lynton sold 12,460 shares of Cardlytics stock in a transaction that occurred on Tuesday, April 2nd. The stock was sold at an average price of $13.69, for a total transaction of $170,577.40. Following the transaction, the insider now owns 71,355 shares of the company's stock, valued at $976,849.95. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, major shareholder Clifford Sosin bought 311,715 shares of the business's stock in a transaction that occurred on Friday, March 15th. The shares were bought at an average cost of $13.71 per share, for a total transaction of $4,273,612.65. Following the transaction, the insider now owns 5,673,676 shares of the company's stock, valued at $77,786,097.96. The disclosure for this purchase can be found here. Over the last quarter, insiders sold 102,427 shares of company stock valued at $736,095. Company insiders own 0.78% of the company's stock.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.